It's not a huge addition but nonetheless positive, as it gives small retail holders confirmation that $6.88 or thereabouts is perceived by this Director as a (more than) acceptable entry price.
Well done.
- Forums
- ASX - By Stock
- FID
- Ann: Appendix 3Y - Change of Director's Interest - SH
Ann: Appendix 3Y - Change of Director's Interest - SH, page-2
Featured News
Add FID (ASX) to my watchlist
(20min delay)
|
|||||
Last
$8.56 |
Change
-0.220(2.51%) |
Mkt cap ! $269.4M |
Open | High | Low | Value | Volume |
$8.60 | $8.71 | $8.56 | $41.08K | 4.772K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 115 | $8.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.69 | 1500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 115 | 8.560 |
1 | 5121 | 8.550 |
2 | 500 | 8.500 |
1 | 230 | 8.450 |
1 | 1440 | 8.410 |
Price($) | Vol. | No. |
---|---|---|
8.690 | 1500 | 1 |
8.720 | 1399 | 1 |
8.780 | 1719 | 3 |
8.800 | 2873 | 1 |
8.810 | 630 | 1 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
FID (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online